Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Recruiting
Observational Study
Neuroblastoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,070 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to find out the genetic and biochemical makeup of your neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These research studies include surface marker analysis, cytogenetics, cancer genes,genome sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow, and hematopoietic stem cell samples will also be test…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Neuroblastic tumors diagnosed in accordance with the International Neuroblastoma Staging System
OR
* Clinically suspected neuroblastic tumors.
PK DRAW INCLUSION CRITERIA (FOR PK DRAWS ONLY):
PK Draw Inclusion Criteria
* Patients who receive naxitamab as part of their stan…
Contacts
Nai-Kong Cheung, M.D., Ph.D.
646-888-2313
CONTACT
Shakeel Modak, MD
212-639-7623
CONTACT